Havana Roasters Coffee Companies Inc. has opened its first licensed retail location, a Cuban Bakery & Sandwich Bar in Hollywood, California. This flagship café introduces authentic Cuban coffee and cuisine to a major new market, serving as a proof of concept and a model for future franchise expansion. The café operates with a limited menu initially, aiming to refine operations before a full launch. This move enhances brand visibility and creates new revenue streams through licensing fees and equity participation.
Havana Roasters Coffee's new Hollywood flagship café opens a fresh chapter, while for readers following the Consumer Cyclical sector, here is Pluang's market snapshot as of Sep 23, 2026 18:02 WIB: Out of 111 priced US Consumer Cyclical stocks tradable on Pluang, 55 rose and 43 fell. Notable movers include Gogoro Inc (GGR) at USD 2.79 with a 1-day change of -2.28% and 100% buy order activity, Funko Inc (FNKO) at USD 5.74 with a 2.14% increase, and Royal Caribbean Cruises Ltd (RCL) at USD 239.86 with a 2.12% rise and 100% buy order activity. The most notable figure is the 100% buy order activity for GGR and RCL.
A Snap insider has sold 20,000 shares as the company's stock has declined by 27% over the last year. This insider sale may signal concerns about the stock's near-term prospects or a personal decision to liquidate holdings. Investors should watch for ...
Dogecoin (DOGE) has gained over $171 million in market cap recently, driven by a broader altcoin rally. Three AI platforms—Grok, Gemini, and ChatGPT—forecast an average price increase to $0.1082 by October 1, 2026, suggesting an 8.82% rise from curre...
Analyst Ali Martinez identifies a bullish reversal for the altcoin SUI following an 83% drop from previous highs. Three key weekly indicators—the Tom DeMark Sequential, SuperTrend, and Parabolic SAR—have flipped to buy signals, confirming a potential...
Micron's stock has risen 18.17% this week, closing at $1,096.16, with Wall Street analysts divided on price targets ranging from hold to $2,000 ahead of its September 30 earnings report. The company expects $50 billion in revenue and $31.00 non-GAAP ...
Bio-Techne shareholders have voted to approve the acquisition agreement with Merck KGaA, marking a key step toward completing the merger. The deal, which combines Bio-Techne's life science tools with Merck's global capabilities, aims to enhance suppo...
